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Background: Widespread use of flow cytometry for immunophenotyping in clinical veterinary medicine is limited
by cost and requirement for considerable laboratory space, staff time, and expertise. The Guava EasyCyte Plus
(Guava Technologies, Hayward, CA, US) is the first, personal, bench-top flow cytometer designed to address these
limitations.
Objective: The aim of this study was to adapt the immunohistochemical protocol used for immunophenotyping of
canine lymphoma to the personal flow cytometer for rapid, effective and user-friendly application to the diagnosis
and prognosis of canine lymphoma and to demonstrate its practicality for widespread veterinary application.
Performance of the personal flow cytometer for immunophenotyping T and B lymphocytes in blood and lymph
nodes from normal dogs and dogs with lymphoproliferative disease, was assessed using only two monoclonal
antibodies (against CD3 and CD21), and by comparison with analysis using two conventional flow cytometers.
Methods: 26 dogs with lymphoproliferative disease (23 with lymphoma, 3 with lymphocytic leukaemia) were
studied along with 15 controls (2 non-lymphoma lymph nodes and 13 non-leukemic bloods. Lymphocytes were
immunostained with fluorescent-labeled, monoclonal antibodies against CD3 and CD21. To assess the effectiveness
of the personal flow cytometer in discrimination between T and B cell immunophenotypes, T and B cell counts for
half the samples (14 blood and 11 lymph node) were also determined using the same method and conventional
flow cytometers (FACSCalibur, Cyan Dako). To assess the effectiveness of the personal flow cytometer in
discriminating between leukocyte types, lymphocyte differential counts were determined for 21 blood samples and
compared with those from automated hematology analyzers (CELL-DYN 3500, n=11 and ADVIA 2120, n=10). Quality
and sub-cellular distribution of immunostaining was assessed using fluorescence microscopy.
Results: The protocol for immunophenotyping took 2 to 3 hours to complete from the point of receipt of sample
to reporting of immunophenotype. The personal flow cytometer differential lymphocyte counts correlated highly
(n=20; r=0.97, p<0.0001) with those of automated haematology analyzers. The personal flow cytometer counts
consistently, but mildly, underestimated the percentages of lymphocytes in the samples (mean bias of −5.3%.). The
personal flow cytometer immunophenotype counts were indistinguishable from those of conventional flow
cytometers for both peripheral blood samples (n=13; r=0.95; p<0.0001; bias of −1.1%) and lymph node aspirates
(n=11,r=0.98; p<0.001; bias of 1%). All but one leukemic and one lymphomatous lymph node sample, out of 26
samples of dogs with lymphoproliferative disease analyzed, could be immunophenotyped as either B or T cells.
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Conclusions: We conclude that use of only 2 monoclonal antibodies is sufficient for immunophenotyping most
cases of canine lymphoma by flow cytometry and enables rapid immunophenotyping. The personal flow cytometer
may be as effectively used for immunophenotyping canine lymphoma as conventional flow cytometers. However,
the personal flow cytometer is more accessible and user-friendly, and requires lower sample volumes.
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Lymphoma is one of the most prevalent cancers in dogs
[1]. Diagnostic testing and prognosis is based on clinical
signs and degree of spread, morphological features of
the lymph node and lymphocytes, and other cytopa-
thologic features such as mitotic rate, and clonality of
antigen-receptor rearrangement or of cluster of differen-
tiation (CD) antigens.
Immunophenotyping CD antigens has contributed sig-
nificantly to both diagnosis and prognosis of lymphoid
neoplasia. This approach measures the binding of la-
belled, monoclonal antibodies to specific intracellular or
surface CD antigens. It is well-established and has long
been used in cell analysis, particularly in the fields of
haematology and immunology [2-4]. For lymphoma, it
can be accomplished using either immunohistochemistry
of tissue-biopsy sections [5] or by immunocytochemistry
of fine needle aspirates. Cytologic analysis can be done
manually on smears using microscopy [6] or on cell sus-
pensions using automated, flow cytometry.
Immunophenotyping is most easily and rapidly ac-
complished by flow cytometry. Flow cytometry of blood,
lymph node and bone marrow samples may improve eva-
luation and prognosis of dogs with lymphoma [4,7-9].
However, in veterinary medicine this technique is mainly
available only as a research tool, rather than for wide-
spread diagnostic use as occurs in human medicine [9].
There are only a few European laboratories that routinely
provide immunophenotyping by flow cytometry for veter-
inary patients. The main barriers associated with the ex-
pansion of flow cytometry in veterinary medicine are the
substantial cost of the analyser, reagents, and facilities, and
the need for advanced training of the instrument opera-
tors. In addition, analysis and interpretation of results re-
quires understanding and knowledge of flow cytometry
and its principles.
It is well documented that immunophenotype of neo-
plastic lymphocytes correlates significantly with the sur-
vival time of dogs with lymphoma and is of significant
value in prognosis [10-15]. In 175 dogs with lymphomas,
T-cell phenotype had shorter relapse-free time (52 versus
160 days, p<0.001) and shorter survival times (153 versus
330 days, p<0.001) than B-cell phenotype [15]. Dobson,
Blackwood et al. 2001 found that the T- cell phenotype
is associated with a significantly shorter recurrence-freeinterval and reduced survival times. Hazard ratio for
T-cell versus B-cell immunophenotype lymphoma was
4, with 95% confidence interval from 1.4 to 11.3, p=0.035.
However, the correlation of immunophenotype with prog-
nosis is not perfect, and exceptions have been identified.
For example, the small and clear T-cell lymphoma has
one of the best prognoses [11]. Thus for prognosis, im-
munophenotyping data must be used along with other
clinical and cytological assessments of degree of spread,
morphologic features, and mitotic rate.
In recent years, multiple research studies involving
immunophenotyping by flow cytometry have been pub-
lished in the veterinary literature [2-4,6,15-20]. However,
limited veterinary availability of flow cytometers, expert-
ise, and reagents is a major limitation to the diagnostic
use of immunophenotyping [9]. Also, the current proto-
cols used in veterinary diagnostics are labour intensive
and time-consuming, involve standard technology, and
have not been customised for widespread diagnostic use
in the clinical pathology laboratory.
The recent development of the personal flow cyto-
meter may overcome the barriers previously associated
with diagnostic use of flow cytometry in veterinary me-
dicine. The personal flow cytometer is a miniaturised,
user-friendly, and affordable version of the standard in-
strument [21] found in dedicated facilities and operated
by dedicated personnel. Different manufacturers name
the instruments they produce “personal”. Such instru-
ments include the different Guava platforms produced
by Millipore, the Accuri C6 from BD Biosciences, the
Attune flow cytometer by Applied Biosystems and the
HPC-100 system by Handyem. The technical bulletin for
the Accuri C6 analyzer from BD Biosciences is entitled
“Making Flow Cytometry Personal”[22] They can be
used in any laboratory and by any laboratory technolo-
gist, and seem ideal for the veterinary clinical pathology
laboratory.
The Guava flow cytometer (Guava Technologies,
Hayward, CA, US) is the first, such personal flow cy-
tometer, and has several advantageous features for vete-
rinary use. It is an automated, easy-to-use, bench-top,
single-cell, analyser that can perform a wide range of
multi-parameter, cell-based assays using light scatter and
multiple fluorescence measurements and also direct mea-
surement of cell counts without the need for reference
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[24], making it ideal for veterinary and diagnostic cytology
applications. It requires far less operator time and expert-
ise, less maintenance and is automated for multiple tube
or microtiter plate sampling. It requires far less bench
space than the standard analyser. The purchase cost is
considerably lower than conventional flow cytometers.
Also, it does not produce voluminous waste, because it
does not use sheath fluid to move the cells through the
analyser [21].
The aim of this study was to adapt the immunoche-
mical protocol used for immunophenotyping of canine
lymphoma to the personal flow cytometer for rapid, ef-
fective and user-friendly application to diagnosis and
prognosis of canine lymphoma and to demonstrate its
practicality for widespread veterinary application. Parts
of this study have also been presented in the 10th and
13th Annual Congresses of the European Society of Vete-




Samples from 58 dogs were obtained: a) 21 peripheral
blood samples (of which 1 was leukemic) were used to
assess the ability of the personal flow cytometer to ef-
fectively discriminate lymphocytes from other leuko-
cytes, based on forward and side light scatter (4 of
these were also immunophenotyped). The non-leukemic
samples were obtained from non-lymphopenic dogs
that presented to the University Veterinary Hospital in
Dublin for a variety of reasons other than lymphoma/
leukaemia. b) 41 samples were used to assess the ability
of the personal flow cytometer to immunophenotype: 23
were lymph node aspirates from dogs with lymphoma, 2
were lymph node aspirates from lymphoma-free dogs,
13 were non-leukemic peripheral blood samples and 3
were leukemic blood samples. Of the 41 samples, im-
munophenotyping results for 25 (14 peripheral bloods
and 11 lymph node aspirates) were compared between
the personal flow cytometer and the conventional ana-
lyzers, and 16 were analyzed on the Guava only as no
other analyzer was available. All investigations were
undertaken within the guidelines of the UCD Animal
Research and Ethics Committee.
Flow cytometry
Instrumentation
The Guava EasyCyte Plus is equipped with a 20 mW,
argon-ion laser of 488 nm, a forward-scatter (FSC) de-
tector, a side-scatter (SSC) detector, and four fluorescence
detectors (525/30 nm, 583/26 nm, 680/30 nm, and 785/
70 nm). The Cyan Dako was equipped with three lasers
(488 nm, 635 nm and 405 nm) and the BD FACSCaliburwith 2 lasers operating at 488 and 635 nm. The Guava
ExpressPro software program (version 5.0) was used for
sample data acquisition on the Guava, and the dedicated
software for the other analyzers (Dako Summit and BD
FACStation respectively).
Data acquisition
Gating strategy and protocol setup was the same for all
instruments. When acquiring data, a lymphocyte gate
was defined, based on the size and granularity of lym-
phocytes depicted on the forward scatter versus side
scatter plot. A debris threshold was set to eliminate
events having low forward and side scatter properties.
The gains for forward and side scatter were set to allow
good visualization of the different cell populations con-
tained in the sample, as well as to give adequate sepa-
ration of groups on the cytogram. This was useful in
order to apply the lymphocyte gate correctly. In lymph
node aspirates, the same principle was followed to set
the debris threshold, but the need for subpopulation
separation was minimal due to the more homogeneous
population of lymphocytes and the high lymphocyte
yield obtained from these samples. A total of 5,000–
20,000 cells within the lymphocyte gate were counted
from each sample. Samples were analyzed together with
negative isotype controls (AbD Serotec Canine Negative
Controls/Isotypes for CD3 and CD21, Oxford, UK, con-
jugated to the same fluorochromes as the monoclonal
antibodies) to allow the accurate establishment of the
limits of fluorescence and exclude fluorescence caused
by auto-fluorescence and by non-specific binding. To
avoid contamination of FITC fluorescence into the PE
channel, fluorescence compensation was set by exami-
ning separately sample lymphocytes stained with anti-
CD3+FITC antibodies and sample lymphocytes stained
with anti-CD21+PE antibodies (no standard controls were
used to set compensation). Compensation factor for the
FITC channel was 9–11% and for the PE channel was
0–0.3%. Forward scatter gain was set at 16x and 100%.
Side scatter gain was set between 475–485 V. For the
FITC channel (GRN), the gain was set at 600–700 V and
for the PE channel (YLW), at 500–600 V.
Quality control
Prior to acquisition, the Guava’s performance was as-
sessed by using the Guava Easy Check kit (Millipore).
The kit is composed of beads and a diluent. According
to manufacturer’s recommendations, a fresh solution of
beads was prepared and run in triplicate daily. The ave-
rage number of particles/ml, the average FSC and SSC
intensities, and the average fluorescence intensities for
green, yellow, red and near infra-red channels were cal-
culated, along with the coefficients of variation (CV%) for
these parameters. If they fell within the range proposed
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and <5% for fluorescence intensities) sample analysis was
performed. The daily quality control and maintenance for
the reference instruments were performed by dedicated
personnel in the core flow cytometry facility used.
Evaluation of guava effectiveness in lymphocyte
identification
In peripheral blood samples no lymphocyte isolation
techniques were applied and no non-lymphocytic mar-
kers were used. Accordingly, it was necessary to demon-
strate that the gate set around events consistent with
lymphocytes (based on their forward and side scatter
characteristics) effectively discriminated them from other
leukocytes. Guava lymphocyte percentages for 21 (20 non-
leukemic and non-lymphopenic peripheral blood samples,
and 1 leukemic) were compared with those obtained by
the conventional, automated haematology analysers (n=11
on the CELL DYN 3500 and n=10 on the ADVIA 2120).
Immunophenotyping
Peripheral blood samples Canine peripheral blood sam-
ples were collected into potassium EDTA (Sarstedt,
Wexford Ireland). The samples were submitted to the
veterinary clinical pathology laboratories at University
College Dublin, University California Davis Veterina-
ry Teaching Hospital, or Central Diagnostic Services,
Cambridge, UK, between May 2008 and December 2011.
All blood samples were initially processed with a haema-
tology analyser; also blood smears were stained with a
Romanowsky-type stain (Aerospray 7120, Wescor, Accu-
Science) and a manual differential count was performed.
Lymph node aspirates
Lymph node samples were obtained by two different
ways: a) for cytological examination, 21 gauge hypoder-
mic needles were used (non-aspiration technique, needle
insertion and redirection without applying negative pres-
sure). The cells were immediately expelled on glass sli-
des using a 5 ml disposable plastic syringe and smears
were prepared, air dried and stained with a Romanowsky-
type stain (Aerospray 7120, Wescor, Accu-Science, Dublin)
b) for flow cytometric examination, 2.5 ml disposable sy-
ringes prefilled with 1 ml of sterile phosphate-buffered sa-
line (PBS) at pH=7.4 and 21 gauge hypodermic needles
were used. The needle was attached on the syringe and
inserted multiple times in the lymph node while applying
negative pressure. Once the fluid became opaque (occa-
sionally blood-tinged), the needle was removed from the
lymph node and the fluid was expelled (with the needle
removed from the syringe) in an EDTA container. Lymph
node aspirates were examined by the conventional hae-
matology analysers (CELL DYN 3500 and ADVIA 2120)to assess their nucleated cell count. Cytospin prepara-
tions (Cytospin 4, Thermoshandon, Thermo Scientific
Kalamazoo, MI, USA) were occasionally obtained from
the lymph node aspirates prior to analysis, stained and
examined by optical microscopy to assess sufficient lym-
phocyte retrieval. If the vast majority of the nucleated
cells were lymphocytes by qualitative assessment, analysis
of the sample was considered possible.
Sample preparation and staining
Samples from the University Veterinary Hospital in
Dublin were analyzed immediately after sampling. Lymph
node aspirates from external practitioners were mixed 1:1
with cell preservative (Streck Cell Preservative, Streck,
USA) and shipped occasionally on ice. They were initially
filtered (Partec, CellTrics, 50 μm filters) and a cell count
was performed on the automated haematology analyzers
to assess the sample cellularity. Aspirates sent from exter-
nal sources were first stained with propidium iodide
(P4170, Sigma-Aldrich) to assess viability and were im-
munophenotyped only if cell viability was >90% to avoid
non-specific staining. Lymphocytes for immunopheno-
typing were obtained from 100 micro liters (μL) of blood;
for lymph node samples a volume containing 0.5-1×
106cells was used based on the previously performed cell
count; direct staining was performed with murine, anti-
canine undiluted monoclonal antibodies added according
to the manufacturer’s recommendations, without being
previously titrated: a) anti-CD3 conjugated with fluores-
cein isothiocyanate (source AbD Serotec CA17.2A12),
or Alexa Fluor 488 (Professor P.F. Moore, University Cali-
fornia, Davis, USA CA17.2A12-IgG-1) (excitation=494 nm,
emission=518 nm), and b) anti-CD21 conjugated with
phycoerythrin (PE, excitation=488 nm, emission=667 nm,
Professor P.F. Moore, University California, Davis, USA
CA2.ID6-IgG-1). The cell suspension was placed in dark
for 30 minutes at room temperature. After staining with
the antibodies, the erythrocytes were lysed if needed (for
blood samples and only for grossly blood contaminated
lymph node aspirates) by adding 900 μL of red cell lysing
solution (Guava Lyse, Guava) to a final volume of 1 ml.
The samples were left in dark for 10–15 minutes at room
temperature and then spun down at 2000 rpm (~200 g,
Spectrafuge 16 M microcentrifuge, Labnet international)
for 5 minutes. If the pellet’s colour was red, the lysing
step was repeated. After red cell lysis, the nucleated cells
were washed twice with phosphate-buffered saline
(PBS) at pH=7.4 containing 3% foetal calf serum. Finally,
the cell suspension was diluted with washing buffer and
the cell concentration was adjusted to less than 500
cells/μL. In most cases, the exact same samples were
analyzed on the personal and the conventional flow
cytometers.
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Two lymphoma lymph node aspirates (B-cell and T-cell)
and one non-cancerous peripheral blood sample previ-
ously stained for immunophenotyping were additionally
examined by fluorescence microscopy in order to assess
the cell type and cell percentage stained, and the sub-
cellular distribution and quality of staining with the
monoclonal antibodies. After being analysed on the per-
sonal flow cytometer, the cells were added into a 96-well
plate with a final concentration of 50,000 to 100,000
cells in 100–200 μL of phosphate buffer saline per well.
They were then incubated with Hoechst (nuclear) stain
(Hoechst 33342, Invitrogen): 1.5 μl of a 1 mM solution
was diluted in 1 ml of phosphate buffered saline pH=7.4
and 100 μl of the final solution was added to each well,
giving a final volume of 200–300 μl. The cells were left
incubating for 15 minutes at room temperature in the
dark. They were examined using the InCell 1000 analyzer
(GE healthcare, Cardiff, UK). The excitation/emission fil-
ters were set as follows: a) Hoechst channel (nuclei): exci-
tation 360 nm, emission 460 nm b) FITC channel (CD3+):
excitation 475 nm, emission 535 nm and c) PE channel
(CD21+): excitation 570 nm, emission 620 nm.
Statistics
Statistical analysis was performed on Graph Pad Prism
version 5.0 (LaJolla, USA). The data was first checked
for normality using D’Agostino and Pearson’s omnibus
normality test (α=0.05). Parametric tests (Pearson’s r)
were used for assessing correlation in normally distrib-
uted data sets and non-parametric tests (Spearman’s r)
for data that were not normally distributed. No attempt
was made to achieve normality. Bias and agreement were
calculated through Bland-Altman analysis. Correlation
was characterized as excellent (r≥0.93), good (r=0.80 to
0.92), fair (r=0.59 to .79) or poor (r ≤0.59) [27,28]. Linear
regression analysis was also performed. The significance
of differences between the means or the medians were
assessed through paired tests for normally (Paired t-test)
and not normally (Wilcoxon matched pairs test) distri-
buted data. When values from a particular sample in a
data set were more than three standard deviations away
from the mean of the rest of them, the sample was consi-
dered an outlier and was removed from the data set [29].
The immunophenotyping results for blood and lymph
node samples were analysed separately and collectively.
Results
The appearance of the personal cytometer scatter plot
for a normal peripheral blood sample and a lymph node
aspirate from a dog with lymphoma are depicted in
Figure 1. There is adequate cell population separation in
both the forward-scatter versus side scatter plots and
the green fluorescence versus yellow fluorescence plots.For the control, non-lymphopenic peripheral blood sam-
ples that were used, there is good visualization of the
lymphocyte population that facilitates their gating. Occa-
sionally, there was an overlap between the lymphocytes
and a cluster of events close to the lower end of both
axes, and/or the cluster of events with higher forward-
scatter and side-scatter values consistent with mono-
cytes. A comparison between the scatter plots generated
by the personal flow cytometer and a conventional ana-
lyzer (Cyan, Dako) for the same sample can be seen in
Figure 2. The appearance of both the forward scatter
versus side scatter and the fluorescence intensity plots is
similar for both instruments.Guava effectiveness in lymphocyte identification
21blood samples were examined for the differential lym-
phocyte counts in total. One sample had to be removed
as an outlier because its value (expressed as the differ-
ence between the personal and the conventional ana-
lyzer) was 10 standard deviations away from the mean of
the rest (also expressed as differences). Based on forward
and side scatter parameters and the positioning of the
lymphocyte gate, the mean lymphocyte percentage for
peripheral blood samples on the Guava was 18.7%±
16.5% (median 15.2%, range 3.1% – 82.8%) and on the
haematology analyzers the mean was 24%±15.2% (me-
dian 20%, range 5.7% – 80%) (Figure 3). A Wilcoxon
matched pairs test showed statistically significant differ-
ence between the medians (p=0.0002). The bias and lin-
ear regression plots are depicted in Figures 4A-4C and
4D-4F respectively. Correlation for lymphocyte percent-
ages between the Guava and both automated haematol-
ogy analyzers was excellent (r=0.97, p<0.0001). Between
the Guava and the CELL DYN 3500 the correlation coef-
ficient was good, r=0.82 (p=0.0033, n=11), and between
the Guava and the ADVIA 2120 it was excellent, r=0.96
(p<0.0001, n=9). The Bland-Altman analysis revealed a
mean negative bias for blood samples of −5.3% (SD of
bias = 4%), and was similar between the Guava and
the CELL DYN 3500 (−6.2%, SD of bias = 4.6%) and
between the Guava and the ADVIA 2120 (−4.2%, SD
of bias = 3.3%).Immunophenotyping
The sample-preparation protocol took approximately 1.5
to 2 hours to perform, from the point of receipt of
sample to the point of starting analysis by the flow
cytometer. The flow cytometric analysis took approxi-
mately 0.5 to 1 h from the point of starting the analysis
to the point of reporting immunophenotypes.
Linear regression and bias plots for immunopheno-
typing showed that the personal analyzer and the con-
ventional analyzers gave similar results and were highly
Figure 1 Scatterplots of immunophenotyping data from the personal flow cytometer for normal blood and a lymphomatous lymph
node. (A) Non- leukemic peripheral blood with debris threshold set on forward scatter, oval lymphocyte gate and population of granulocytes, (B)
Non-lymphoma peripheral blood immunophenotypes: 78% of the cells contained in the lymphocyte gate are CD3+ and 12.6% CD21+, the rest
being mostly unstained events (C-D) B-cell lymphoma in a lymph node aspirate, 98.5% of the gated cells are CD21+.
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(Figures 5 and 6).Blood samples
14 samples were examined in total, but one sample had
to be removed as an outlier since its value (expressed as
the difference between the personal and conventional
flow cytometer) was 15 standard deviations away from
the mean of the rest (also expressed as differences). Co-
efficient of correlation was excellent (r=0.95, p<0.0001)
when percentages for both CD3+ and CD21+ cells were
assessed together. For CD3+ cells it was good(r=0.90,
p<0.0001), and for CD21+ cells it was excellent (r=0.97,
p<0.0001). The Guava showed a negative mean bias
of −1.1% for blood immunophenotypes (SD of bias =
6.5%), which was negative for CD3+ cells (−2.8%, SD
of bias=8.9%) and positive for CD21+ cells (0.5%, SD
of bias=1.8%).Lymph node aspirates
11 lymph node aspirates were examined. Correlation
was excellent for CD3+ (r=0.97, p<0.0001), CD21+ cells
(r=0.98, p<0.0001) and also for CD3+ and CD21+ cells
combined (r=0.98, p<0.0001) between the Guava and the
conventional flow cytometers. The mean bias for the
lymph node samples was 1% (SD of bias = 7.2%) with
a positive bias for the different immunophenotypes
(0.8%, SD=7.4% for CD3+ cells, and 1.3%, SD=7.3%
for CD21+ cells).
Overall, for all the blood and lymph node samples
(n=24) that were compared between the Guava and the
conventional analyzers and for both CD3+ and CD21+
cells, the coefficient of correlation was excellent (r=0.96,
p<0.0001, n=48) and the Guava showed a mean negative
bias of −0.1% (SD of bias = 6.9%) (Figures 5I and 6I).
With the 2 antibody protocol that was used, 24 out of
26 dogs (92%) with lymphoproliferative disease were
successfully immunophenotyped (Figure 7). One lymph
Figure 2 Comparison of scatterplots of immunophenotyping data from the personal and conventional flow cytometers for leukemic
blood. Peripheral blood sample from a dog diagnosed with (CD 21+) large B-cell lymphoma based on clinical findings, lymph node cytology and
lymph node immunophenotyping. The dog had a WBC count of 38.7×109/L (ADVIA 2120) with 55% lymphocytes (21.3×109/L). Predominance of
(CD21+) lymphocytes (area R5 of the scatterplots). Scatterplots (A) and (C) show the total events as acquired by the personal and the conventional
analyzer respectively (2 times more events were acquired by the conventional for this sample). The lymphocyte gate is showed containing 34% of
the total events for the Guava and 53% for the conventional analyzer. Scatterplots (B) and (D) illustrate the immunophenotyping results: the Guava
gave 64% (CD21+), 10.2% (CD3+), 21.7% double positive and 4.3% double negative. The conventional analyzer gave 71.7% (CD21+), 10.1% (CD3+),
13% double positive and 5.2% double negative events (Dako Summit v4.3 was used to analyze data).
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of acute lymphoblastic leukaemia were negative for both
antibodies. The 24 tumors successfully immunopheno-
typed were 11 T-cell lymphomas, 11 B-cell lymphomas
and 2 T-cell leukaemias. In most cases there was clear
predominance of one cell type (≥50%) allowing the im-
munophenotype identification.
Fluorescence microscopy images revealed staining of
most of the small mononuclear cells consistent with
lymphocytes with no non-specific binding. The staining
intensity was high, and the tagged antibodies were uni-
formly dispersed across the cell membranes with no
intracellular localization (Figure 8).
Discussion
Novel features of immunophenotyping approach
This study demonstrates a simple and cost-effective ap-
proach to diagnostic application of flow cytometry in theclinical pathology laboratory for immunophenotyping
lymphoma. It is based on an adaptation of a standard,
immunohistochemistry protocol and the use of the per-
sonal flow cytometer.
The protocol is based on using the most simple stra-
tegy and assay for immunophenotyping of most canine
lymphomas, that is, using single T and B cell surface
markers. Intracellular markers for flow cytometry are
more technically demanding and the evaluation panel
is frequently restricted to easily accessible surface anti-
gens only, although it has become evident that some
lineage markers are already expressed in the cytoplasm
very early in differentiation [30]. The surface panel ap-
proach simplifies the immunophenotyping assay, re-
duces assay time and thereby minimizes interference
with other laboratory activities, and also reduces sam-
ple volume requirement and allows application when
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Figure 3 Comparison of differential lymphocyte counts and
immunophenotypes from the personal and conventional flow
cytometers. The bars illustrate the mean ± SD for the percentages
obtained by the Guava and the conventional analyzers: differential
lymphocyte percentage (peripheral blood), and (%) CD3+, (%) CD21+
for the blood samples and the lymph node aspirates. * Group
differences significant at p < 0.001.
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leukaemias.
The personal flow cytometer is a scaled-down version
of the conventional analyser, but with most of its func-
tional capacity, and also with substantial technological
differences [21]. It has numerous advantages for the
clinical pathology laboratory over the conventional flow
cytometer. The latter is usually located in a remote




















































































Figure 4 Comparison of differential, blood, lymphocyte counts on the
Bland-Altman bias and linear regression plots. The mean bias (central d
indicated in the bias plots and the regression line with 95% confidence int
CELL DYN 3500, (B and E) % lymphocytes Guava versus ADVIA 2120, (C antechnologists, has multiple users, and requires pre-
scheduling for use [9]. In contrast, the personal flow
cytometer is easily and immediately accessible because
its small size and lower bench-space requirement allow
it to be situated directly in the clinical pathology lab.
Also, it is generally less complicated to use and easier
for clinical pathology technologists to learn a specific
assay on [31]. Use of microcapillary technology results
in lower volume requirements for both samples and re-
agents, thereby reducing assay cost as well as sample
size [24,32,33]. In most cases in this study, the Guava
used less than 100 μL per sample, whereas the conven-
tional instruments consumed significantly more. Main-
tenance is reduced because of the elimination of sheath
fluid which is used in conventional cytometers to cause
the cells to flow past the laser beam. The smaller ana-
lyser size is associated with a lower cost of purchase, as
well as low cost of maintenance and operation.
There were also technical advantages of the personal
flow cytometer. The Guava provided absolute cell counts
without a need for reference beads, which are frequently
required by the conventional analysers [34]. Another de-
sirable feature of the Guava is its automation. It is
equipped with a plate holder for analyzing samples from
96-well plates, and can also hold and analyze samples
from up to ten different tubes at once without user in-
terference. The cleaning steps before, between and after
sample analysis are performed automatically. We were
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Figure 5 Comparison of lymphocyte immunophenotypes in blood and lymph node aspirates determined on the personal and
conventional flow cytometer: linear regression plots. Results for cell types (%) obtained by the Guava and the conventional analyzers.
Regression line and 95% confidence interval. (A-C) % CD3+, % CD21+ and collectively % CD3+ and % CD21+ in peripheral blood samples. (D-F) %
CD3+, % CD21+, and collectively % CD3+ and % CD21+ in lymph node aspirates. (G-I) % CD3+, % CD21+ and collectively % CD3+ and % CD21+ in
all peripheral blood and lymph node samples.
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be easily removed to be cleaned or substituted.Correlation and bias of personal versus conventional flow
cytometers and automated haematology analysers
For cell identification and the determination of the
percentage of lymphocytes in peripheral blood samples,
there was good (r=0.80–0.92) to excellent (r≥0.93) cor-
relation between the Guava and the automated haema-
tology analyzers. Whole blood lysis results in samples
containing a mixture of peripheral blood leukocytes, and
a method for identifying the population of interest was
required. We used the simplest approach of separating
leukocytes depending on their forward scatter and side
scatter characteristics, after setting a threshold to ex-
clude cell debris. Alternatively, specific surface immuno-
markers or density gradient separation for the isolation
of mononuclear cells/lymphocytes could have been used
[35], but that would add to the preparation and analysis
time; it is reported that density gradient separation
should probably not be used in samples containingabnormal lymphocytes, as they may have altered density
and could be lost during preparation [36].
The difference plots for the lymphocyte percentages
indicate that there is a small negative bias (−5.3%) bet-
ween the Guava and the conventional analyzers. The un-
derestimation of lymphocyte percentages by the Guava
is similar for both conventional analyzers. The haematol-
ogy analyzers used are designed for and specialize in
performing differential cell counts for peripheral blood
samples. The CELL DYN 3500 uses optical and impe-
dance methodology, while the ADVIA 2120 also uses
cytochemical staining to discriminate between the differ-
ent cell types. The sample processing before the differ-
ential count was different for the two methods, as the
samples analyzed on the Guava had to undergo manual
red cell lysis and then centrifugation and washes. It is
possible that there was a loss of lymphocytes during the
preparation procedure. Also, the monocytes were not al-
ways readily identified as a separate population, and the
gating had to be tightly set around lymphocytes to avoid
overlap with other cell populations. This probably also






































































































Figure 6 Bland-Altman bias plots for immunophenotyping lymphocytes in blood and lymph node aspirates using the personal
compared to the conventional flow cytometer. Difference versus average for cell percentages. Mean bias (central dot-line) and limits of
agreement (upper and lower dotted lines). (A-C) % CD3+, % CD21+ and % CD3+ and % CD21+ in peripheral blood samples. (D-F) % CD3+, %
CD21+, and % CD3+ and % CD21+ in lymph node aspirates. (G-I) % CD3+, % CD21+ and % CD3+ and % CD21+ in all peripheral blood and























Figure 7 T and B immunophenotype predominance in
lymphoproliferative disease (23 lymphomas; 3 lymphocytic
leukaemias). (%) CD21+ and (%) CD3+ percentages obtained by
the Guava analyzer for the lymphoma / leukaemia samples included
in this study. The percentages are shown separately for the T-cell,
the B-cell and the non-T non-B cell tumors. There is clear separation
between the cell populations allowing the identification of the
predominant immunophenotype in most cases.
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analyzers.
Our finding of cost-effective, accurate and rapid im-
munophenotyping of canine lymphoma using the per-
sonal flow cytometer is similar to the findings of other
studies on immunophenotyping lymphocytes in HIV
infection in humans [24,31,33,34,37,38]. These studies
used a similar approach by assessing correlation and
agreement with linear regression and Bland-Altman bias
analysis. For immunophenotyping of lymphocytes, the
correlation for T-cell and B-cell percentages was excel-
lent for the blood samples and the lymph node aspirates
(r=0.95 and r=0.98 respectively, p<0.0001). In the differ-
ence plots, there is a slight mean bias that is negative for
blood samples (−1.1%) and positive for lymph node aspi-
rates (1%). The bias variation increases for higher mea-
surements, with similar distribution across the line of
identity. Since, in this study, the purpose is to identify
which cell population shows marked predominance com-
pared to the other, in order to identify the predominant
immunophenotype, the magnitude of this bias is unlikely
to affect the final outcome.
Figure 8 Fluorescence microscopy images of immunophenotyped lymphocytes of blood and lymph nodes from a healthy dog and
dogs with lymphoma. Lymphocytes stained with anti-CD3+FITC (green color) and anti-CD21+PE (red color) antibodies and Hoechst nuclear
stain (blue color), original magnification 40×. (A) Fused image (360 nm, 480 nm, 525 nm) of normal peripheral blood from a dog, predominance
of (CD3+) T-lymphocytes. (B) B-cell lymphoma, lymph node aspirate (picture taken after excitement at 525 nm). All the cells seen are (CD21+)
(C) T-cell lymphoma, lymph node aspirate (picture taken after excitement at 480 nm). All the cells seen are (CD3+) T-lymphocytes.
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immunophenotyping
A total of 41 samples were immunophenotyped (26 from
dogs with lymphoproliferative disease, and 15 disease-
free dogs) and 2/41 samples did not stain with either of
the antibodies used. All 13 disease-free dogs and 24 out
of 26 cases (92%) with lymphoproliferative disease were
successfully immunophenotyped. In most of the latter,
there is a clear predominance of one immunophenotype
compared to the other, and the tumour was classified
according to the predominant cell type. It has been
reported that a cut off of 60% can be used to classify the
tumour as B- or T-cell type [39], and that in human
medicine a cut off of >20% of the gated cells is used to
consider a marker expressed, but no specific guidelines
for veterinary medicine have been reported[4]. In our
cases, the predominant cell type (in the tumors that
were not negative for both markers) was ≥60% of the
gated cells in all samples but one lymph node aspirate,
in which ~50% of the gated cells were CD3 positive and
~7% CD21positive. Based on the predominance of
T-cells and the cytological diagnosis of lymphoma, the
tumour was considered to be of the T-cell phenotype.
Both antibodies in this study were surface markers.
CD3 is considered a pan T-cell marker expressed in
early thymocytes and throughout the maturation of the
cell [39]. CD21 is a surface marker expressed on mature
B cells [39], but is frequently used due to its convenience.
We have used the intracytoplasmic CD79a in the past, but
found that it significantly prolongs the sample preparation
time and is more technically demanding. Two-antibody
immunophenotyping is frequently used in immunohisto-
chemistry / immunocytochemistry [5,6] and is likely to
cover the majority of the cases encountered in routine
practice. The approach that we followed for the use ofantibodies was the simplest possible. The amount of anti-
body solution used per test was provided by the manu-
facturers. A titration study was not performed prior to
use, although no significant differences in immunopheno-
typing results were seen when serially diluted antibody
solutions (up to 1:10 with PBS) were used for non lymph-
oma / leukaemia blood samples (data not shown). How-
ever, the same may not apply to cancerous samples as
surface receptor expression may be altered.
Immunophenotyping (whether performed on the per-
sonal and the conventional machines or the personal
flow cytometer only) revealed approximately equal num-
bers of B-cell and T-cell tumors. Most studies in ca-
nines typically show a predominance of the B-cell type
[5,8,15,17,18,20], although a mild, T-cell lymphoma pre-
dominance was reported in one study [11]. One double
negative lymph node aspirate and one leukemic blood
sample were identified, as has also been described in other
studies [5,15] but no other reported aberrant types de-
scribed [39,40] were encountered.
Fluorescence microscopy
The fluorescence microscopy images proved useful in
order to assess the quality and distribution of staining. As
expected by using surface markers, the tagged antibodies
were localized across the cell membranes. The majority of
the small mononuclear cells consistent with lymphocytes
for each field of view were stained with no non-specific or
intracellular binding. The predominant cell types in the
fluorescence images were in accordance to the predomin-
ant cell types obtained by flow cytometry.
Limitations of the study
There are several limitations of this study that should be
considered when interpreting the results.
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Only two, monoclonal, species-specific, surface markers
were used in this study although cross-reacting anti-
bodies from other species have frequently been used in
other studies [5,18,20]. Flow cytometric studies of im-
munophenotypes in canine lymphoma commonly use
an extensive panel of surface and occasionally intracel-
lular markers [4,16,18,20,35,39,41]. Our purpose was
to minimize complexity and difficulty, and develop a
widely-accessible working protocol for diagnostic use
that would cover the majority of tumors (in our case
92% were successfully immunophenotyped). Investiga-
tion and understanding of the complex pathophysiologic
mechanisms involved in the development and spread of
canine lymphoma, requires an extensive antibody panel.
Prognostic value of T versus B staining
Cytological examination of all the lymphoma cases pre-
sented in this study, revealed a predominance of me-
dium and large lymphocytes [42-44], and the mitotic rate
was estimated on the cytological specimens as has been
described before [3]. No follow-up study was performed
to assess the association between the immunophenotype
and the disease-free intervals and survival times. How-
ever, these have been previously described [10-14]. The
morphological, immunophenotypic, clinicopathological
and clinical information should be assessed collectively
to provide more prognostic information.
Number of samples
The Clinical and Laboratory Standards Institute (CLSI)
recommends at least 40 samples to be analyzed in a full,
comprehensive method comparison study in which both
accuracy and precision are assessed [45]. However, this
is a partial comparison study in which we mainly fo-
cus on correlation and precision. The calculated sam-
ple size needed to detect a relevant correlation (r>0.7)
with a specified significance level (α=0.05) and power
(1-β=0.95) is at least 20 samples [46,47]. The number
of samples for cross-comparison of lymphocyte percent-
ages and immunophenotypes in this study meet this cri-
terion (21 and 25 respectively). The limited number of
samples reflects the caseload of our laboratory as well as
the limited request of immunophenotyping by the vete-
rinary practitioners. An attempt was made to increase
the numbers by analysing samples from the University
California Davis Veterinary Teaching Hospital and Central
Diagnostic Services, Cambridge, UK and also by analysing
blood samples from lymphoma/leukaemia free dogs.
Use of haematology analyzers for lymph node aspirate
counts
The automated hematology analyzers were used to as-
sess the cellularity of the sample upon receiving it. If thecell count was low, the sample was considered unsui-
table and discarded or, if possible, the sampling was re-
peated. The cell count obtained by the analyzer was
used to adjust the cellularity prior to staining and ac-
quisition. We consider acquiring cell counts for lymph
node aspirates by haematology analyzers a reasonable ap-
proach since these machines have been validated and used
extensively for performing cell counts in a variety of fluids
other than blood in both human and veterinary medicine
[48-50].
Sample viability during storage and transport
External peripheral blood samples were shipped to our
laboratory in EDTA containers, and lymph node aspi-
rates in tubes with cell-preservative as described in the
materials and methods section. Cell preservatives have
been evaluated and found to maintain the integrity of
white cells for at least 7 days [51,52], although in our
case the samples were analyzed within 24 hours of sam-
ple collection. Blood and lymph node aspirates sent with
no ice packs occasionally showed low viability in pro-
pidium iodide staining and had to be discarded. The rea-
son for the low viability cannot be easily identified and
may also be related to the sampling technique. No sig-
nificant differences in the immunophenotypes of sam-
ples analyzed immediately versus those stored at 4°C
for12-16 h was found in one study [35].
Conclusion
This is the first report of a stream-lined, user-friendly,
cost-effective immunophenotyping strategy for immuno-
phenotyping canine lymphoma by flow cytometry in the
veterinary, clinical pathology laboratory. We demons-
trate that the simplest technical approach is inexpensive,
rapid and highly effective at immunophenotyping most
lymphomas in the dog. We also demonstrate that the
personal flow cytometer (Guava EasyCyte Plus) is more
suitable than the conventional flow cytometer for the
clinical pathology lab for routine diagnostics.
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